Boothbay Fund Management’s CytomX Therapeutics CTMX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$70.5K	Sell	15,000 -879,663	-98%	-$4.47M	﹤0.01%	1897
2025 Q4	$3.81M	Sell	894,663 -342,394	-28%	-$1.3M	0.1%	372
2025 Q3	$3.95M	Buy	+1,237,057	New	+$2.79M	0.1%	375
2022 Q3	–	Sell	-20,054	Closed	-$37K	–	2308
2022 Q2	$37K	Buy	20,054 +6,953	+53%	+$13.3K	﹤0.01%	2110
2022 Q1	$35K	Buy	+13,101	New	+$50.3K	﹤0.01%	2212
2021 Q3	–	Sell	-15,182	Closed	-$96K	–	1963
2021 Q2	$96K	Sell	15,182 -80,102	-84%	-$624K	﹤0.01%	1745
2021 Q1	$737K	Buy	+95,284	New	+$754K	0.04%	743
2020 Q3	–	Sell	-14,595	Closed	-$122K	–	1093
2020 Q2	$122K	Buy	14,595 +695	+5%	+$6.45K	0.01%	858
2020 Q1	$107K	Buy	+13,900	New	+$96.9K	0.01%	720
2019 Q1	–	Sell	-10,000	Closed	-$151K	–	782
2018 Q4	$151K	Buy	+10,000	New	+$148K	0.03%	515